Prescription drug cost sharing: associations with medication and medical utilization and spending and health
ContextPrescription drugs are instrumental to managing and preventing chronic disease.
Recent changes in US prescription drug cost sharing could affect access to them …
Recent changes in US prescription drug cost sharing could affect access to them …
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries
MC Gemmill, S Thomson, E Mossialos - International journal for equity in …, 2008 - Springer
As pharmaceutical expenditure continues to rise, third-party payers in most high-income
countries have increasingly shifted the burden of payment for prescription drugs to patients …
countries have increasingly shifted the burden of payment for prescription drugs to patients …
Pharmaceutical policies: effects of cap and co‐payment on rational use of medicines
VL Luiza, LA Chaves, RM Silva… - Cochrane Database …, 2015 - cochranelibrary.com
Background Growing expenditures on prescription medicines represent a major challenge
to many health systems. Cap and co‐payment policies are intended as an incentive to deter …
to many health systems. Cap and co‐payment policies are intended as an incentive to deter …
Cold summer weather, constrained restoration, and the use of antidepressants in Sweden
Constraint of restorative activities prolongs chronic stress and may exacerbate depressive
symptoms. Treating unseasonable weather as an ecological constraint on restorative …
symptoms. Treating unseasonable weather as an ecological constraint on restorative …
Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures?: Interrupted time series analysis of cost, volume and cost per volume …
K Andersson, MG Petzold, C Sonesson, K Lönnroth… - Health policy, 2006 - Elsevier
The last decades increasing pharmaceutical expenditures in Sweden and other western
countries have created a need for reforms to reduce the trend. The aim was to analyse if …
countries have created a need for reforms to reduce the trend. The aim was to analyse if …
Work-related sleep disturbances and sickness absence in the Swedish working population, 1993–1999
H Westerlund, K Alexanderson, T Åkerstedt… - Sleep, 2008 - academic.oup.com
Abstract Study Objectives: To examine secular trends in work-related sleep disturbances
and their association with sickness absence in the Swedish working population. Design …
and their association with sickness absence in the Swedish working population. Design …
[PDF][PDF] Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries
C Leopold, AK Mantel-Teeuwisse… - Bulletin of the World …, 2014 - SciELO Public Health
Objective To identify pharmaceutical policy changes during the economic recession in eight
European countries and to determine whether policy measures resulted in lower sales of …
European countries and to determine whether policy measures resulted in lower sales of …
Vacation, collective restoration, and mental health in a population
Vacations enable people to help one another, spend time together in pleasant contexts, and
renew relational resources. Reasoning that these shared activities spread social and …
renew relational resources. Reasoning that these shared activities spread social and …
The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain
I Moreno-Torres, J Puig-Junoy, JM Raya - The European Journal of Health …, 2011 - Springer
The growth in expenditure on the financing of pharmaceuticals is a factor that accounts for a
large part of the increase in public health spending in most developed countries. In an …
large part of the increase in public health spending in most developed countries. In an …
Copayments for prescription medicines on a public health insurance scheme in Ireland
SJ Sinnott, C Normand, S Byrne… - … and drug safety, 2016 - Wiley Online Library
Purpose We assessed the impact of the introduction of a€ 0.50 prescription copayment, and
its increase to€ 1.50, on adherence to essential and less‐essential medicines in a publicly …
its increase to€ 1.50, on adherence to essential and less‐essential medicines in a publicly …